1.
通过protein-SELEX筛选的核酸适体
| 靶标蛋白 | 核酸适体名称 | 核酸适体长度(nt) | 解离常数(nmol/L) | 靶标蛋白相关肿瘤 | 文献 | 
| CD123 | ZW25 | 66 | 29.41 | 急性髓细胞白血病 | [18] | 
| CY30 | 66 | 15.38 | |||
| RUNX1 | S4-S | 52 | 3.5±0.4 | 急性髓细胞白血病 | [19] | 
| RUNX1 | Apt1-S | 38 | 0.99±0.22 | 急性髓细胞白血病 | [20] | 
| β-arrestin-2 | β-att2A1 | 79 | 19.83 | 慢性髓细胞白血病 | [21] | 
| β-att2A2 | 80 | 4.13 | |||
| β-att2A3 | 80 | 22.03 | |||
| E-selectin、P-selectn | SDA | 91 | 98±16 | 嗜酸性粒细胞白血病 | [22] | 
| CD117 | CD117-specific aptamer | 81 | 4.24 | 急性髓细胞白血病 | [23] | 
| mIgM | R1.1 | 59 | 73.2±13.7 | 伯基特淋巴瘤 | [24] | 
| R1.2 | 41 | 35.5±8.9 | |||
| CD30 | C2NP | 31 | 2 | 间变性大细胞淋巴瘤霍奇金淋巴瘤 | [25] | 
| NGS6.0NP | 30 | 100 | |||
| CD40 | CD40Apt1 | 65 | 20 | B细胞淋巴瘤 | [26] | 
| CD40Apt3 | 65 | 10 | |||
| Tenascin-C | TTA1 | 39 | 50 | 胶质母细胞瘤 | [27] | 
| midkine | Apt-1 | 40 | - | 神经母细胞瘤 | [28] | 
| WT1 | RNA20 | 78 | 87.4±10.4 | 肾母细胞瘤 | [29] | 
| RNA22 | 77 | 13.8±1.1 | |||
| RNA38 | 77 | 17.8±1.4 | |||
| HMGA2 | HMGA2-aptamer | 23 | - | 视网膜母细胞瘤 | [30] | 
| PDGFRβ | Gint4.T | 33 | 9.6 | 胶质细胞瘤 | [31] |